BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15145452)

  • 1. Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge.
    Chambers MA; Gavier-Widén D; Hewinson RG
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):93-100. PubMed ID: 15145452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A DNA vaccine encoding MPB83 from Mycobacterium bovis reduces M. bovis dissemination to the kidneys of mice and is expressed in primary cell cultures of the European badger (Meles meles).
    Chambers MA; Stagg D; Gavier-Widén D; Lowrie D; Newell D; Hewinson RG
    Res Vet Sci; 2001 Oct; 71(2):119-26. PubMed ID: 11883890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83.
    Chambers MA; Vordermeier H; Whelan A; Commander N; Tascon R; Lowrie D; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S283-7. PubMed ID: 10875801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
    Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
    Fan X; Gao Q; Fu R
    Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.
    Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral infection of ferrets with virulent Mycobacterium bovis or Mycobacterium avium: susceptibility, pathogenesis and immune response.
    Cross ML; Labes RE; Mackintosh CG
    J Comp Pathol; 2000 Jul; 123(1):15-21. PubMed ID: 10906251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of mice with a Mycobacterium tuberculosis genomic expression library results in lower bacterial load in lungs after challenge with BCG.
    Hernández YL; Corona DY; Rodríguez SS; Infante Bourzac JF; Sarmiento ME; Arzuaga NO; Maceo EC; Díaz D; Díaz R; Domínguez AA
    Tuberculosis (Edinb); 2006; 86(3-4):247-54. PubMed ID: 16647298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunologic characteristics of monoclonal antibodies to Mycobacterium Bovis and four affinity-purified mycobacterial antigens].
    Liashchenko KP; Bobrovnik CA; Gorbenko EV; Kolesnikova IN; Bukhanevich AM; Liashko ED; Komissarenko SB
    Probl Tuberk; 1993; (5):41-4. PubMed ID: 7507592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathogenesis of experimental Mycobacterium bovis infection in mice.
    Chambers MA; Gavier-Widen D; Hewinson RG
    Res Vet Sci; 2006 Feb; 80(1):62-70. PubMed ID: 15922378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium bovis DeltaleuD auxotroph-induced protective immunity against tissue colonization, burden and distribution in cattle intranasally challenged with Mycobacterium bovis Ravenel S.
    Khare S; Hondalus MK; Nunes J; Bloom BR; Garry Adams L
    Vaccine; 2007 Feb; 25(10):1743-55. PubMed ID: 17240005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel monoclonal antibodies against major antigens of Mycobacterium bovis.
    Lyashchenko KP; Wiker HG; Harboe M; McNair J; Komissarenko SV; Pollock JM
    Scand J Immunol; 2001 May; 53(5):498-502. PubMed ID: 11309158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific identification of Mycobacterium bovis by monoclonal antibody-based enzyme immunoassay.
    Liashchenko KP; Bil'ko IP; Kolesnykova IM; Liashko KD; Matiash MA; Mikhal's'kyĭ LO; Smirnov VV; Komisarenko SV
    Mikrobiol Z; 1997; 59(3):46-53. PubMed ID: 9347689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.